In breast cancer treated with catalpol, Kac, 2-hydroxyisobutyrylation, and Kla were significantly increased, whereas succinylation, propionylation, and phosphorylation were significantly decreased, suggesting that catalpol may inhibit breast cancer progression by regulating different types of PTMs 49. Here, KL is linked to breast carcinoma.